Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
Go back to Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer| Sunshine Biopharma, Inc. (NASDAQ: SBFM) | Delayed: 1.14 -0.01 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.15 | 52 Week High | $0.04 | |||
| Open | $1.14 | 52 Week Low | $0.00 | |||
| Day High | $1.14 | P/E | N/A | |||
| Day Low | $1.13 | EPS | $0.00 | |||
| Volume | 16,896 | |||||
